Director| Greehey Children's Cancer Research Institute, UT Health at San Antonio, San Antonio, TX 78229 - USA
Consultant to the Pharmaceutical & Biotechnology Industry, Newton, PA - USA
Assistant Professor | Department of Biochemistry and Molecular Genetics; Director | Central Alabama High-Field NMR Facility; Co-Director | Structural Biology Shared Facility, Cancer Center, The University of Alabama at Birmingham - USA
Vice President | FORMA Therapeutics - 500 Arsenal Street, Watertown, MA 02472 - USA
Director | Molecular Therapeutics Program - Geisel School of Medicine at Dartmouth, USA
Professor & Chair Newman H Waters Chair of Clinical Pharmacology | Department of Pharmacology & Toxicology, University of Alabama at Birmingha, USA
VP, Disease Strategy Head, Lung Cancer Global Clinical Lead, Lung Cancer Immuno-Oncology - AstraZeneca,
1800 Concord Pike, Wilmington, DE 19803 - USA
Chief Scientific Officer | ORIC Pharmaceuticals,
240 E. Grand Avenue, South San Francisco, CA 94080 - USA
Agon Consulting, Paris -
126 Boulevard Pereire, 75017 Paris, France
Harrison Distinguished Professor |
Departments of Pharmacology and Chemistry,
University of Virginia, USA
Senior Director | Department of Discovery Oncology
Adjunct Professor | Department of Biochemistry and Biophysics, School of Medicine, UCSF
Genentech Inc. |
1 DNA Way | South San Francisco, CA 94080
Professor of Medicine | Pharmacology Department of Experimental Therapeutics - MD Anderson Cancer Center,
1515 Holcombe Boulevard Unit 1950
Houston, TX 77030 - USA
Director | Stanford Clinical & Translational Research Unit; Co-director | Stanford University Center for Clinical & Translational Education & Research (Spectrum) - Stanford University School of Medicine, Stanford, CA 94305 - USA
Senior Vice President |
IMED Oncology,
AstraZeneca -
Cambridge Science Park, Cambridge,
United Kingdom
Chief Scientific Officer |
Peloton Therapeutics -
2330 Inwood Road, Suite 226,
Dallas, TX 75235-7323
- USA
Cumming-Presidential Professor | Cancer Biology & Senior Director | Preclinical Translation, Huntsman Cancer Institute & Dept. of Dermatology -
University of Utah, Salt Lake City,
UT 84112 USA
The Cancer Molecular Therapeutics Research Association [CMTRA] was created in 2008 to organize and host the annual Molecular Therapeutics of Cancer meeting. The meeting objective is to provide a forum for presentation and discussion of contemporary research in the field of cancer drug development and therapy. Modeled after small Gordon-type conferences, the meeting provides an opportunity for young and established researchers to discuss and challenge current paradigms for cancer drug development and therapy, as well as a venue where novel ideas can be presented with anticipation of lively debate.
at Granlibakken Tahoe Resort & Conferenec Center, Lake Tahoe, CA
(Twelveth Meeting)
at Sundance, Utah
(Eleventh Meeting)
at Hilton Burlington Hotel, Burlington, Vermont
(Tenth Meeting)
at University of Washington, Seattle, Washington
(Ninth Meeting)
at Tufts University, Medford, Massachussetts
(Eighth Meeting)
at Asilomar, Pacific Grove, Californias
(Seventh Meeting)
at University of Colorado, Boulder, Colorado
(Sixth Meeting)
at Princeton University
(Fifth Meeting)
at The Asilomar Conference Center
(Fourth meeting)
at The Asilomar Conference Center
(Third meeting)
at Stanford University
(Second meeting)
at Princeton University
(First meeting)
8403 Floyd Curl Drive, MSC 7784
San Antonio, TX 78229
210.562.9161
210.562.9014
aguilarv@uthscsa.edu